Browsing byAuthorNair, PC
Showing results 1 to 3 of 3
Issue Date | Title | Author(s) |
2021-02-05 | Differential inhibition of human CYP2C8 and molecular docking interactions elicited by sorafenib and its major N-oxide metabolite. | Nair, PC; Gillani, TB; Rawling, T; Murray, M |
2019-11-01 | Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib | Murray, M; Gillani, TB; Rawling, T; Nair, PC |
2019-03-01 | Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4 | Ghassabian, S; Gillani, TB; Rawling, T; Crettol, S; Nair, PC; Murray, M |